IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharmaceuticals: Nycomed to Shift European API Production to India

5:16 AM MDT | March 17, 2008 | Ed Berrigan

Pharmaceuticals firm Nycomed (Zurich, Switzerland) says it plans to transfer its current API production from facilities at Linz (Austria) and Singen (Germany) to Zydus Nycomed (Mumbai, India) in the next three-to-four years. Zydus Cadila (Ahmedabad, India) says that Zydus Nycomed its joint venture company with Nycomed will now become an active pharma ingredient (API) manufacturing hub. A letter of agreement has been signed between the two companies to amend their existing joint venture agreement to include the chemical production of APIs and this new development...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa